Taken together, these results suggested the prognosis‐related tumor antigens including IGF2BP3, DPCR1, HOXD10, TRIM7, and ZIC5 were promising targets of being developed as mRNA vaccines against COAD. This evidence concerns the gene TRIM7 and colon adenocarcinoma.